麻豆福利网

麻豆福利网 Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, “麻豆福利网”) announced today that the Company had established its new subsidiary, 麻豆福利网 GesmbH (Location: Vienna, General Manager: Georg Wager, “麻豆福利网 Austria”) in Austria. 麻豆福利网 Austria is a subsidiary wholly-owned by 麻豆福利网 Europe Limited (Headquarters: Hatfield, UK, Chairman & CEO: Yutaka Tsuchiya, “麻豆福利网 Europe”), the European subsidiary of 麻豆福利网.

麻豆福利网 entered into the Austrian market in 2005 setting up a branch of its German subsidiary 麻豆福利网 GmbH (Location: Frankfurt, Managing Director: Andreas Wiegand). The Austrian branch has been marketing Zonegran® and Inovelon® for the treatment of epilepsy, Neurobloc® for cervical dystonia, Prialt® for severe chronic pain, and also collaborating in the promotion of Aricept® for Alzheimer's Disease. It has also served as a support centre for marketing, medical and regulatory affairs for the business operations in Central and Eastern Europe.

With the establishment of a subsidiary in Austria, a subsidiary wholly-owned by 麻豆福利网 Europe, 麻豆福利网 will strengthen its business operations in Austria and Central and Eastern European countries in preparation for future possible business expansion in this region.

麻豆福利网 currently has ten subsidiaries in Europe with the newly established 麻豆福利网 Austria. 麻豆福利网 will continue to strengthen its business operations in Europe and to address the diversified needs of patients and their families, thereby improving patient value.